9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Species within the Aspergillus spp. cause a wide range of infections in humans, including invasive pulmonary aspergillosis, chronic pulmonary aspergillosis, and allergic bronchopulmonary aspergillosis, and are associated with high mortality rates. The incidence of pulmonary aspergillosis (PA) is on the rise, and the emergence of triazole-resistant Aspergillus spp. isolates, especially Aspergillus fumigatus, limits the efficacy of mold-active triazoles. Therefore, host-directed and novel adjunctive therapies are required to more effectively combat PA. In this review, we focus on PA from a microbiome perspective. We provide a general overview of the effects of the lung and gut microbiomes on the growth of Aspergillus spp. and host immunity. We highlight the potential of the microbiome as a therapeutic target for PA.

          Related collections

          Most cited references81

          • Record: found
          • Abstract: found
          • Article: not found

          Induction of intestinal Th17 cells by segmented filamentous bacteria.

          The gastrointestinal tract of mammals is inhabited by hundreds of distinct species of commensal microorganisms that exist in a mutualistic relationship with the host. How commensal microbiota influence the host immune system is poorly understood. We show here that colonization of the small intestine of mice with a single commensal microbe, segmented filamentous bacterium (SFB), is sufficient to induce the appearance of CD4(+) T helper cells that produce IL-17 and IL-22 (Th17 cells) in the lamina propria. SFB adhere tightly to the surface of epithelial cells in the terminal ileum of mice with Th17 cells but are absent from mice that have few Th17 cells. Colonization with SFB was correlated with increased expression of genes associated with inflammation and antimicrobial defenses and resulted in enhanced resistance to the intestinal pathogen Citrobacter rodentium. Thus, manipulation of this commensal-regulated pathway may provide new opportunities for enhancing mucosal immunity and treating autoimmune disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision

            Fungal diseases kill more than 1.5 million and affect over a billion people. However, they are still a neglected topic by public health authorities even though most deaths from fungal diseases are avoidable. Serious fungal infections occur as a consequence of other health problems including asthma, AIDS, cancer, organ transplantation and corticosteroid therapies. Early accurate diagnosis allows prompt antifungal therapy; however this is often delayed or unavailable leading to death, serious chronic illness or blindness. Recent global estimates have found 3,000,000 cases of chronic pulmonary aspergillosis, ~223,100 cases of cryptococcal meningitis complicating HIV/AIDS, ~700,000 cases of invasive candidiasis, ~500,000 cases of Pneumocystis jirovecii pneumonia, ~250,000 cases of invasive aspergillosis, ~100,000 cases of disseminated histoplasmosis, over 10,000,000 cases of fungal asthma and ~1,000,000 cases of fungal keratitis occur annually. Since 2013, the Leading International Fungal Education (LIFE) portal has facilitated the estimation of the burden of serious fungal infections country by country for over 5.7 billion people (>80% of the world’s population). These studies have shown differences in the global burden between countries, within regions of the same country and between at risk populations. Here we interrogate the accuracy of these fungal infection burden estimates in the 43 published papers within the LIFE initiative.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Microbiota regulates immune defense against respiratory tract influenza A virus infection.

              Although commensal bacteria are crucial in maintaining immune homeostasis of the intestine, the role of commensal bacteria in immune responses at other mucosal surfaces remains less clear. Here, we show that commensal microbiota composition critically regulates the generation of virus-specific CD4 and CD8 T cells and antibody responses following respiratory influenza virus infection. By using various antibiotic treatments, we found that neomycin-sensitive bacteria are associated with the induction of productive immune responses in the lung. Local or distal injection of Toll-like receptor (TLR) ligands could rescue the immune impairment in the antibiotic-treated mice. Intact microbiota provided signals leading to the expression of mRNA for pro-IL-1β and pro-IL-18 at steady state. Following influenza virus infection, inflammasome activation led to migration of dendritic cells (DCs) from the lung to the draining lymph node and T-cell priming. Our results reveal the importance of commensal microbiota in regulating immunity in the respiratory mucosa through the proper activation of inflammasomes.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                12 August 2022
                2022
                : 13
                : 988708
                Affiliations
                [1] 1 Shanghai Engineering Research Center of Lung Transplantation , Shanghai, China
                [2] 2 Basic School of Medicine, Second Military Medical University (Naval Medical University) , Shanghai, China
                [3] 3 Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine , Shanghai, China
                [4] 4 Division of Mycology, Department of Microbiology, Faculty of Medicine, University of Çukurova , Adana, Turkey
                [5] 5 Department of Pharmacy, 905th Hospital of People’s Liberation Army of China (PLA) Navy , Shanghai, China
                [6] 6 Shanghai Engineering Research Center of Hadal Science and Technology, College of Marine Sciences, Shanghai Ocean University , Shanghai, China
                Author notes

                Edited by: Wenjie Fang, Shanghai Changzheng Hospital, China

                Reviewed by: Lei Zhang, Shaanxi Provincial People’s Hospital, China; Xiaojing Li, Affiliated Hospital of Hebei University of Engineering, China

                *Correspondence: Xiaochun Xue, xxc2021@ 123456126.com ; Jinzhou Xiao, signal611@ 123456163.com ; Chang Chen, chenthoracic@ 123456163.com

                †These authors have contributed equally to this work and share first authorship

                This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2022.988708
                9411651
                36032147
                3f9da8b5-3cc4-4ed0-bb2e-696c37b4939b
                Copyright © 2022 Cai, Gao, Wang, Dai, Ning, Ilkit, Xue, Xiao and Chen

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 07 July 2022
                : 25 July 2022
                Page count
                Figures: 1, Tables: 1, Equations: 0, References: 81, Pages: 7, Words: 3232
                Funding
                Funded by: Science and Technology Commission of Shanghai Municipality , doi 10.13039/501100003399;
                Categories
                Immunology
                Mini Review

                Immunology
                pulmonary aspergillosis,fungal diseases,aspergillus,immunity,microbiome
                Immunology
                pulmonary aspergillosis, fungal diseases, aspergillus, immunity, microbiome

                Comments

                Comment on this article